The Non-Malignant Channel on VJHemOnc is an independent medical education platform, supported with funding from Agios (Gold). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISTH 2022 | COVID-19 vaccination in patients with ITP
Hanny Al-Samkari
• 12 Jul 2022
Hanny Al-Samkari, MD, Massachusetts General Hospital, Harvard Medical School, Boston, MA, comments on the safety of COVID-19 vaccination in patients with immune thrombocytopenia (ITP). Despite concerns that these vaccines could exacerbate ITP, currently available data indicates that the vaccine is safe for most patients with ITP. This interview took place at the 30th Congress of the International Society on Thrombosis and Haemostasis (ISTH) 2022 held in London, UK.
